상침자(桑椹子)추출물이 ob/ob mouse의 혈당, 혈청 지질, Polyol Pathway, AGE 및 RAGE에 미치는 영향

Effects of Mori Fructus Extract on Hyperglycemia, Hyperlipidemia, Polyol Pathway, AGE and RAGE in ob/ob Mice

  • 이민동 (동국대학교 한의과대학 내과학교실) ;
  • 정지천 (동국대학교 한의과대학 내과학교실)
  • Lee, Min-Dong (Department of Internal Medicine, College of Korean Medicine, Dongguk University) ;
  • Jeong, Ji-Cheon (Department of Internal Medicine, College of Korean Medicine, Dongguk University)
  • 발행 : 2009.04.25

초록

Etiological studies of diabetes and its complications showed that oxidative stress might play a major role, Therefore, many efforts have been tried to regulate free oxygen radicals for treating diabetes and its complications. Mori Fructus extract has been known to be effective for the antidiabetic, antihyperlipidemic and antiobesitic prescription, and composed of four crude herbs, The aim of this study was to investigate the effect of Mori Fructus extract in male ob/ob mouse with severe obesity, hyperinsulinemia, hyperglycemia, hyperlipidemia. Mice were grouped and treated for 5 weeks as follows. Both the lean (C57BL/6J black mice) and diabetic (ob/ob mice) control groups received standard chow. The experimental groups were fed with a diet of chow supplemented with 7.5, 15 and 30 mg Mori Fructus extract per 1 kg of body weight for 14 days. The effects of Mori Fructus extract on the ob/ob mice were observed by measuring the serum levels of glucose, insulin, lipid components, and the kidney levels of reactive oxygen species (ROS), MDA+HAE, GSH and also the enzyme activities involved in polyol pathway. Western blotting was performed using anti-AGE, anti-RAGE respectively. Mori Fructus extract lowered the levels of serum glucose and insulin in a dose dependent manner. Total cholesterol, triglyceride and free fatty acid levels were decreased, while the HDL-cholesterol level was increased, in Mori Fructus extract treated groups. Renal aldose reductase and sorbitol dehydrogenase activities were increased in the ob/ob mice, whereas those were inhibited in the Mori Fructus extract-administered groups. Mori Fructus extract inhibited the generation of ROS in the kidney. MDA+HAE level was increased and the GSH level was decreased in the ob/ob mice, whereas those were improved in the Mori Fructus extract-administered groups. Mori Fructus extract inhibited the expression of AGE, RAGE in the ob/ob mice. The results suggested that Mori Fructus exerted the antidiabetic and antihyperlipidemic activities by regulating the activities of polyol pathway enzymes, scavenging the ROS, decreasing the MDA+HAE level, increasing the GSH level and inhibiting the expression of AGE, RAGE in the ob/ob mice.

키워드

참고문헌

  1. Kahn, C.R. The molecular mechanism of insulin action. Ann Rev Med. 34: 145-160, 1985
  2. 김응진 외. 당뇨병학. 서울, 고려의학, pp 15-43, 32-33, 149-169, 391-468, 475-487, 609-616, 1998
  3. Carmine, M., Giuseppe, L., Bruno, T. Insulin resistance and cardiovascular risk ; New insight from molecular and cellular biology. Trends cardiovasc Med. 16: 183-188, 2006 https://doi.org/10.1016/j.tcm.2006.03.008
  4. Clay, F.S. Insulin resistance and atherosclerosis. J Clin Invest. 116: 1813-1822, 2006 https://doi.org/10.1172/JCI29024
  5. Cai, H., Harrison, D.G. Endothelial dysfunction in cardiovascular diseases ; the role of oxidant stress. Circ Res. 87: 840-844, 2000 https://doi.org/10.1161/01.RES.87.10.840
  6. Matsubara, T., Ziff, M. Increased syperoxide anion release from human endothelial cells in response to cytokines. J Immunol. 137: 3295-3298, 1986.
  7. Hammers, H.D., Martin, S., Fedesrlin, K., Geisen, K. and Brownlee, M. Aminoguanidine treatment inhibit the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA. 88: 11555-11558, 1991 https://doi.org/10.1073/pnas.88.24.11555
  8. Pugliese, G., Tilton, G.T. and Williamson, J.R. Glucose- induced metabolic imbalance in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev. 7: 35-59, 1991 https://doi.org/10.1002/dmr.5610070106
  9. Stevens, M.J., Dananberg, J., Feldman, E.L., Lattimer, S.A., Kamijo, M., Thomas, T.P., Shindo, H., Sima, A.A. and Greene, D.A. The linked roles of nitric oxide, aldose reductase and Na-K-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest. 94: 853-859, 1994 https://doi.org/10.1172/JCI117406
  10. Schmidt, A.M., Vianna, M., Gerlach, M., Brett, J., Ryan, J., Kao, J., Seposito, C., Hegarty, H., Hurley, W. and Clauss, M. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung tissue which are present on the endothelial cell surface. J Biol Chem. 267: 14987-14997, 1992
  11. Brownlee, M., Cerami, A. and Vlassara, H.N. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. Engl J Med. 318: 1315-1321, 1988 https://doi.org/10.1056/NEJM198805193182007
  12. Neeper, M., Schmidt, A.M., Brett, J., Yan, S.D., Wang, F., Pan, Y.C.E., Ellisoton, K., Stern, D. and shaw, A.J. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. Biol Chem. 267: 14998-15004, 1992
  13. Schmidt, A.M., Yan, S.D., Wautier, J.L. and Stern, D. Activation of receptor for advanced glycosylation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res. 84: 489-497, 1999 https://doi.org/10.1161/01.RES.84.5.489
  14. 方藥中. 實用中醫內科學. 上海, 上海科學技術出版社, p 477, 1986.
  15. 余永譜. 中醫治療內分泌代謝疾病. 浙江, 浙江科學技術出版社, p 239, 243, 1992
  16. 강석봉. 消渴의 傳變證과 당뇨병의 만성합병증에 대한 비교 고찰. 대한한의학회지 19(2):137-152, 1998
  17. 한기선. ob/ob mice에서 順氣散의 항당뇨 활성 및 기전 연구. 경희대학교 대학원 석사학위논문, 2002
  18. 한상태, 정지천. 淸血散이 ob/ob mouse의 혈당, 고지혈증, Polyol Pathway 및 Reactive Oxygen Species에 미치는 영향. 동의생리병리학회지 22(2):350-356, 2008
  19. 江蘇新醫學院 編. 中藥大辭典. 上海, 上海科學技術出版社, pp 1967-1968, 1983
  20. 全國韓醫科大學 本草學敎授 共編. 本草學. 서울, 永林社, pp 598-599, 1991
  21. 라정찬, 배진희, 박형근, 김성훈, 강경선. 당뇨 환자를 위한 새로운 식이요법제에 관한 연구. 동의생리병리학회지 17(1):130-135, 2006
  22. 박용기, 강병수. 桑椹子의 항산화작용에 관한 연구. 대한본초학회지 14(2):43-50, 1999
  23. 황금희. 상심자(Morus alba)의 운동능력 향상과 스트레스 개선 효과. 한국식품과학회지 37(1):95-102, 2005
  24. Thomson, R.H. Colorimetric glucose oxidase method for blood glucose. Clin Chem Acta. 13: 133-135, 1966 https://doi.org/10.1016/0009-8981(66)90281-6
  25. Levinson, S.S. Use of an enzymatic method for cholesterol, designed for continuous flow instrumention, with discrete bichromatic and centrifugation analysis. Clin Chem. 23: 2335-2337, 1977
  26. Flether, M.J. A colorimetric method for estimation serum triglyceride. Clin Chem. 22: 393, 1968 https://doi.org/10.1016/0009-8981(68)90041-7
  27. 金井泉 외. 臨床檢査法槪要. 동경, 금원. p 467, 1983
  28. Yamaoka, T., Nishimura, C., Yamashita, K., Itakura, M., Yamada, T., Fujimoto, J. and 3Kokai, Y. Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia. 38: 255-261, 1995 https://doi.org/10.1007/BF00400627
  29. Hollmann, S. In Hoppe-Seyler Thiefelder : Handbuch der physiol. und path.-chem. Vol. VIa. Berlin-Heidelberg-New York:Analyse, Springer. p 704, 1964
  30. Cathcart, R., Schwiers, E., Ames, B.N. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein fluorescent assay. Anal Biochem. 134: 111-116, 1983 https://doi.org/10.1016/0003-2697(83)90270-1
  31. Esterbauer, H., Schaur, R.J. and Zollner, H. Chemistry and Biochemistry of 4-Hydroxynonenal, Malondialdehyde and Related Aldehydes. Free Rad Biol Med. 11: 81-128, 1991 https://doi.org/10.1016/0891-5849(91)90192-6
  32. Ellman, G.L. Tissue sulfhydryl group arch. Biochem Biophys. 82: 70-77, 1959 https://doi.org/10.1016/0003-9861(59)90090-6
  33. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J. Protein measurement with folin phenol reagent. J Biol Chem. 193: 265-275, 1951
  34. Polonsky, K.S. et al. Non-insulin dependent diabetes mellitus. A genetically programmed failure of the $\beta$ cell to compensate for insulin resistance. New Engl J Med. 334: 777-783, 1998 https://doi.org/10.1056/NEJM199603213341207
  35. Steinberg, G.R. Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle. 6: 888-894, 2007 https://doi.org/10.4161/cc.6.8.4135
  36. 정해주, 김세윤, 정지천. 고지방 식이 흰쥐의 비만에 미치는 三精丸의 영향. 대한한의학회지 27(3):516-527, 2006
  37. Eleazar, S. Animal models of non-insulin-dependent diabetes. Diabetes metabolism reviews. 8(3):179-208, 1992 https://doi.org/10.1002/dmr.5610080302
  38. Vinson, J.A. and Howard, T.B. Inhibition of protein glycation and advanced glycation end products by ascorbic and other vitamines and nutrients. Nutritional Biochemistry. 7: 659-663, 1996 https://doi.org/10.1016/S0955-2863(96)00128-3
  39. Smith, P.R. and Thornalley, P.J. Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. Eur J Biochem. 210: 729-739, 1992 https://doi.org/10.1111/j.1432-1033.1992.tb17474.x
  40. Schleicher, E.D., Wagner, E., Nerlich, A.G. Increasedaccumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest. 99(3):457-468, 1997 https://doi.org/10.1172/JCI119180